LV12492B - PHARMACEUTICAL COMPOSITIONS OF TIZOXANIDE AND NITROXOSANIDE - Google Patents

PHARMACEUTICAL COMPOSITIONS OF TIZOXANIDE AND NITROXOSANIDE Download PDF

Info

Publication number
LV12492B
LV12492B LVP-99-170A LV990170A LV12492B LV 12492 B LV12492 B LV 12492B LV 990170 A LV990170 A LV 990170A LV 12492 B LV12492 B LV 12492B
Authority
LV
Latvia
Prior art keywords
acid
formula
compound
composition according
particle size
Prior art date
Application number
LVP-99-170A
Other languages
English (en)
Latvian (lv)
Other versions
LV12492A (en
Inventor
Jean-Francois Rossignol
Original Assignee
Romark Laboratories, L.C.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27420362&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LV12492(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US08/852,447 external-priority patent/US5968961A/en
Priority claimed from US08/887,809 external-priority patent/US5965590A/en
Priority claimed from US08/887,810 external-priority patent/US5856348A/en
Application filed by Romark Laboratories, L.C. filed Critical Romark Laboratories, L.C.
Publication of LV12492A publication Critical patent/LV12492A/xx
Publication of LV12492B publication Critical patent/LV12492B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A61P33/12—Schistosomicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
LVP-99-170A 1997-05-07 1999-12-01 PHARMACEUTICAL COMPOSITIONS OF TIZOXANIDE AND NITROXOSANIDE LV12492B (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US08/852,447 US5968961A (en) 1997-05-07 1997-05-07 Pharmaceutical compositions of tizoxanide and nitazoxanide
US08/887,809 US5965590A (en) 1994-09-08 1997-07-03 Method for treatment of opportunistic infections with pharmaceutical compositions of tizoxanide and nitazoxanide
US08/887,810 US5856348A (en) 1994-09-08 1997-07-03 Method for treatment of trematodes with pharmaceutical compositions of tizoxanide and nitazoxanide
PCT/US1998/009229 WO1998050035A1 (fr) 1997-05-07 1998-05-06 Compositions pharmaceutiques de tizoxanide et de nitazoxanide

Publications (2)

Publication Number Publication Date
LV12492A LV12492A (en) 2000-06-20
LV12492B true LV12492B (en) 2001-01-20

Family

ID=27420362

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-99-170A LV12492B (en) 1997-05-07 1999-12-01 PHARMACEUTICAL COMPOSITIONS OF TIZOXANIDE AND NITROXOSANIDE

Country Status (35)

Country Link
EP (2) EP1005342B1 (fr)
JP (1) JP3739802B2 (fr)
KR (2) KR100426657B1 (fr)
CN (2) CN1158074C (fr)
AP (1) AP1103A (fr)
AR (1) AR057242A2 (fr)
AT (2) ATE281166T1 (fr)
AU (1) AU740022B2 (fr)
BG (2) BG109365A (fr)
BR (1) BR9808722A (fr)
CA (2) CA2288003C (fr)
CZ (2) CZ298270B6 (fr)
DE (2) DE69809928T2 (fr)
DK (2) DK1222921T3 (fr)
EA (2) EA002920B1 (fr)
EE (1) EE04870B1 (fr)
ES (2) ES2232687T3 (fr)
GE (1) GEP20032970B (fr)
HK (1) HK1025907A1 (fr)
HU (1) HU229641B1 (fr)
IL (2) IL155799A (fr)
IS (1) IS2087B (fr)
LV (1) LV12492B (fr)
ME (1) ME00530B (fr)
NO (2) NO313983B1 (fr)
NZ (2) NZ500149A (fr)
OA (1) OA11169A (fr)
PL (1) PL193275B1 (fr)
PT (2) PT1222921E (fr)
RO (1) RO120605B1 (fr)
SI (1) SI20149B (fr)
SK (2) SK283947B6 (fr)
TR (1) TR199902733T2 (fr)
UA (2) UA57079C2 (fr)
WO (1) WO1998050035A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2467321A1 (fr) 2004-05-14 2005-11-14 Paul J. Santerre Agents de couplage polymeres et polymeres ayant une activite pharmaceutique produits a partir de ceux-ci
ZA200806310B (en) 2006-01-09 2009-12-30 Romark Lab Lc Viral hepatitis treatment
PL2395840T3 (pl) * 2009-02-13 2020-09-07 Romark Laboratories, L.C. Preparaty farmaceutyczne nitazoksanidu o kontrolowanym uwalnianiu
SG10201402281WA (en) 2009-05-12 2014-07-30 Romark Lab Lc Haloalkyl heteroaryl benzamide compounds
BRPI1014322A2 (pt) 2009-06-26 2015-08-25 Romark Lab Lc Método para tratar infecção, e para interromper ou evitar a produção de partículas virais infecciosas, combinação, e, composição farmacêutica.
BR112014018149B1 (pt) 2012-01-27 2020-09-29 Siegfried Rhein S.A. De C.V Composição farmacêutica de nitazoxanida
JP6633092B2 (ja) * 2014-11-11 2020-01-22 ロマーク ラボラトリーズ，リミティド カンパニー チゾキサニド、その類似体又は塩のプロドラッグを用いる組成物及び治療方法
US11612567B2 (en) 2018-02-02 2023-03-28 Ripple Therapeutics Corporation Ocular inserts comprising a covalently linked steroid dimer
CA3176134A1 (fr) 2020-05-01 2021-11-04 Ripple Therapeutics Corporation Compositions heterodimeres et methodes pour le traitement de troubles oculaires
WO2022130406A1 (fr) * 2020-12-15 2022-06-23 Cipla Limited Composition pour inhalation composée de nitazoxanide ou de ses dérivés s'utilisant dans le traitement d'une maladie à coronavirus

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1437800A (en) * 1973-08-08 1976-06-03 Phavic Sprl Derivatives of 2-benzamido-5-nitro-thiazoles
US4315018A (en) * 1978-12-07 1982-02-09 Rossignol Jean F Specific parasiticidal use of 2-benzamido-5-nitro-thiazole derivatives
US5578621A (en) * 1994-09-08 1996-11-26 Romark Lab Lc Benzamide derivatives
US5387598A (en) * 1994-04-13 1995-02-07 Rossignol; Jean-Francois Composition and galenic formulation suitable for combatting affections of the lower abdomen

Also Published As

Publication number Publication date
DK1005342T3 (da) 2003-03-24
TR199902733T2 (xx) 2000-03-21
AR057242A2 (es) 2007-11-21
NO335781B1 (no) 2015-02-16
NO995406D0 (no) 1999-11-04
DE69809928D1 (de) 2003-01-16
AP9901675A0 (en) 1999-12-31
CA2418634C (fr) 2004-10-26
BR9808722A (pt) 2000-07-11
NO20021832D0 (no) 2002-04-18
BG109365A (en) 2006-08-31
EA002920B1 (ru) 2002-10-31
PL193275B1 (pl) 2007-01-31
KR20040004544A (ko) 2004-01-13
CN1158074C (zh) 2004-07-21
HK1025907A1 (en) 2000-12-01
UA74388C2 (uk) 2005-12-15
EP1222921A1 (fr) 2002-07-17
HUP0003330A3 (en) 2002-10-28
IL155799A (en) 2004-08-31
DE69827417T2 (de) 2005-10-27
OA11169A (en) 2003-04-25
PL336805A1 (en) 2000-07-17
BG103958A (en) 2000-07-31
EE9900578A (et) 2000-08-15
ES2150404T1 (es) 2000-12-01
BG64973B1 (bg) 2006-11-30
ATE281166T1 (de) 2004-11-15
RO120605B1 (ro) 2006-05-30
NO995406L (no) 2000-01-04
CN100515420C (zh) 2009-07-22
IL132516A0 (en) 2001-03-19
CZ298269B6 (cs) 2007-08-08
EP1005342B1 (fr) 2002-12-04
ES2150404T3 (es) 2003-07-01
ME00530B (me) 2011-10-10
GEP20032970B (en) 2003-05-27
NO313983B1 (no) 2003-01-13
EA200100956A1 (ru) 2002-02-28
JP3739802B2 (ja) 2006-01-25
WO1998050035A1 (fr) 1998-11-12
EE04870B1 (et) 2007-08-15
DE69809928T2 (de) 2003-04-24
LV12492A (en) 2000-06-20
SK283947B6 (sk) 2004-05-04
SK283946B6 (sk) 2004-05-04
JP2001503067A (ja) 2001-03-06
IL155799A0 (en) 2003-12-23
AP1103A (en) 2002-09-04
IS5223A (is) 1999-10-19
CA2288003C (fr) 2003-10-21
KR100426657B1 (ko) 2004-04-13
IS2087B (is) 2006-03-15
KR100576646B1 (ko) 2006-05-08
SI20149B (en) 2001-08-31
EA199901012A1 (ru) 2000-08-28
CZ391199A3 (cs) 2000-07-12
NO20021832L (no) 2000-01-04
AU7289598A (en) 1998-11-27
SK151199A3 (en) 2000-07-11
IL132516A (en) 2003-12-10
DE69827417D1 (de) 2004-12-09
PT1005342E (pt) 2003-02-28
UA57079C2 (uk) 2003-06-16
NZ513881A (en) 2002-10-25
DK1222921T3 (da) 2005-03-07
EA002908B1 (ru) 2002-10-31
EP1005342A4 (fr) 2001-02-07
ATE228839T1 (de) 2002-12-15
EP1005342A1 (fr) 2000-06-07
EP1222921B1 (fr) 2004-11-03
CN1255060A (zh) 2000-05-31
SI20149A (sl) 2000-08-31
CA2418634A1 (fr) 1998-11-12
CN1552322A (zh) 2004-12-08
ES2232687T3 (es) 2005-06-01
HU229641B1 (en) 2014-03-28
HUP0003330A2 (hu) 2001-05-28
PT1222921E (pt) 2005-02-28
AU740022B2 (en) 2001-10-25
NZ500149A (en) 2001-11-30
KR20010020322A (ko) 2001-03-15
CA2288003A1 (fr) 1998-11-12
CZ298270B6 (cs) 2007-08-08

Similar Documents

Publication Publication Date Title
US5965590A (en) Method for treatment of opportunistic infections with pharmaceutical compositions of tizoxanide and nitazoxanide
LT4751B (lt) Tizoksanido ir nitazoksanido farmacinės kompozicijos
EP1222921B1 (fr) Compositions pharmaceutiques contenant du tizoxanide et/ou du nitazoxanide
US5856348A (en) Method for treatment of trematodes with pharmaceutical compositions of tizoxanide and nitazoxanide
FI120258B (fi) Bentsamidijohdannainen, mainittua johdannaista sisältävät koostumukset ja sen käyttö
AU756451B2 (en) Pharmaceutical compositions of tizoxanide and nitazoxanide
MXPA99010215A (en) Pharmaceutical compositions of tizoxanide and nitazoxanide